PARP inhibitors in cancer: moving beyond BRCA LANCET ONCOLOGY Telli, M. L. 2011; 12 (9): 827-828

View details for DOI 10.1016/S1470-2045(11)70236-4

View details for Web of Science ID 000294293500003

View details for PubMedID 21862406